Clinical trial · Interventional
Information-providing Chatbot
The Development and Evaluation of a Co-designed, AI-based Information-providing Chatbot for Sarcoma Patients: A Pilot Randomised Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to develop and examine the feasibility and preliminary effectiveness of an AI-based sarcoma chatbot building on ChatGPT (ASCC) to address the information needs of sarcoma patients. We hypothesized: 1) the ASCC will demonstrate good usability; 2) the study will be feasible in terms of all feasibility indicators; 3) the experimental group will report improved satisfaction and self-efficacy, decreased anxiety and stress than the control groups upon completion of the intervention. The ASCC will be developed using a co-design approach. A pilot randomized controlled trial will then be conducted in the three oncology wards of collaborative hospitals. Seventy-eight sarcoma patients will be recruited and randomized to the experimental group (n=39) and the control group (n=39). The experimental group will use the ASCC available 24/7 via voice or text for disease-related questions for one month while the control group will receive usual care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Sarcoma | Sarcoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ASCC (sarcoma-specific AI chatbot) | Other | — | UNRESOLVED |
| Routine Clinical Care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- ASCC
- description
- An AI-based sarcoma chatbot building on ChatGPT (ASCC) using a co-design approach.
- interventionNames
- Other: ASCC (sarcoma-specific AI chatbot)
- type
- OTHER
- label
- Control
- description
- The standard information from doctor-patient consultations and hospital
- interventionNames
- Other: Routine Clinical Care
Primary outcomes (9)
- measure
- Screening rate
- timeFrame
- During the enrollment period of this project.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * (1) diagnosed with soft tissue sarcoma; * (2) receiving active treatment at any stage; * (3) aged≥18 years; * (4) able to speak Cantonese, Mandarin and English; * (5) access to an electronic device enabling ASCC use Exclusion Criteria: * (1) patients with unstable physical or mental conditions; * (2) inability to communicate logically; * (3) using chatbots (e.g., ChatGPT, Deepseek) for sarcoma information in the last month; * (4) mental health disorders documented by the medical system
References
Publications (0)
Data not yet available